Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase IIa study of KY0467 granules in children with hand, foot and mouth disease
CTR20222189Phase 2Active
- Sponsor
- Jiangsu Kanion Pharmaceutical Co., Ltd.
- Start
- Aug 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of KY0467, sponsored by Jiangsu Kanion Pharmaceutical Co., Ltd.. Started Aug 2022; status: active.
02
Drugs
KY0467
Beyond the preview
Go deeper on CTR20222189.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20222189.